戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 phosphorylation, is completely inactive with ceramide kinase.
2 lipase A2 (cPLA2alpha) or down-regulation of ceramide kinase.
3 ed during phagocytosis through activation of ceramide kinase.
4 es not serve as substrate for the neutrophil ceramide kinase.
5 agocytic index in association with increased ceramide kinase activation and translocation to lipid ra
6                                              Ceramide kinase activation occurs in a time-dependent fa
7            Our method is useful for assaying ceramide kinase activity both in vitro and in cultured c
8                           Current assays for ceramide kinase activity employ [(32)P]ATP, with separat
9                                              Ceramide kinase and its product ceramide 1-phosphate hav
10 tudy identifies previously unknown roles for ceramide kinase and its product, C-1-P, in AA release an
11 e predicted that protein CpgB functions as a ceramide kinase and performs the first step in generatin
12               Recently, we demonstrated that ceramide kinase, and its product, ceramide 1-phosphate (
13                                     This new ceramide kinase assay is more specific than the commonly
14  that ceramide 1-phosphate (C1P) produced by ceramide kinase (CERK) is a negative regulator of LPS-in
15                           We now report that ceramide kinase (Cerk) is required for mammary tumor rec
16                   We characterized the first ceramide kinase (CERK) mutant in any organism.
17                                              Ceramide kinase (CERK) phosphorylates ceramide to produc
18 t manner although mRNA and protein levels of ceramide kinase (CERK) remained stable.
19 1-phosphate is formed by a calcium-dependent ceramide kinase, found predominately in the neutrophil p
20 raction of Bwa with CDase and the Drosophila ceramide kinase gene (DCERK).
21                           Down-regulation of ceramide kinase had no effect on AA release induced by e
22                     We studied whether human ceramide kinase (hCERK) activity and ceramide 1-phosphat
23                              C1P produced by ceramide kinase is an activator of group IVA cytosolic p
24                                  Recombinant ceramide kinase is highly active and ceramide is the onl
25 w that the sphingolipid biosynthetic enzyme, ceramide kinase, is a novel regulator of PLC signaling a
26 nal ceramide metabolism, specifically in the ceramide kinase like (CERKL) gene.
27                                         Thus ceramide kinase-mediated maintenance of ceramide level i
28  ceramide kinase specifically down-regulated ceramide kinase mRNA and activity with a concomitant dec
29 more, the pharmacological inhibitor of human ceramide kinase (NVP-231) had no effect on CpgB.
30      The characterization of a new bacterial ceramide kinase opens avenues for understanding the stru
31 increase in ceramide, resulting from lack of ceramide kinase, perturbs the membrane microenvironment
32 labeled lipid in organic solvent extracts of ceramide kinase reactions.
33                 RNA interference targeted to ceramide kinase specifically down-regulated ceramide kin
34                                A mutation in ceramide kinase specifically leads to proteolysis of NOR
35 veloped a fluorescent plate reader assay for ceramide kinase that uses commercially available C6-NBD
36    Collectively, these results indicate that ceramide kinase, via the formation of C-1-P, is an upstr
37                                        Human ceramide kinase was recently cloned and characterized.
38  the production of C-1-P in mammalian cells, ceramide kinase, was activated in response to IL-1beta a
39                            Using recombinant ceramide kinase, we have now developed a rapid and speci
40 revealed that CpgB belongs to a new class of ceramide kinases, which is distinct from its eukaryotic